MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)

Phase 2

Terminated

Conditions: Depression

Interventions: Drug: Scopolamine

First Posted Date: 2011-03-11

Last Posted Date: 2017-05-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 7

Registration Number: NCT01312844

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Biological: BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein)

First Posted Date: 2011-03-10

Last Posted Date: 2015-10-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 8

Registration Number: NCT01311817

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Terminated

Conditions: Major Depressive Disorder w/ Psychotic Features
Metabolic Syndrome
Major Depressive Disorder

First Posted Date: 2011-03-08

Last Posted Date: 2017-02-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 14

Registration Number: NCT01310140

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Quantification of Outcome Measures for Mind-body Interventions

Not Applicable

Completed

Conditions: Stress, Psychological
Stress, Physiological

Interventions: Behavioral: Stress Management Group 2
Behavioral: Stress Management Group 3
Behavioral: Stress Management Group 1

First Posted Date: 2011-03-04

Last Posted Date: 2015-11-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 455

Registration Number: NCT01308970

Locations: 🇺🇸
Benson-Henry Institute for Mind Body Medicine; Massachusetts General Hospital, Boston, Massachusetts, United States

Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.

Not Applicable

Terminated

Conditions: Local Anesthetics

Interventions: Drug: Lidocaine
Drug: alkalinized lidocaine
Drug: normal saline

First Posted Date: 2011-02-25

Last Posted Date: 2017-04-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 29

Registration Number: NCT01304082

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Improving Empathy and Relational Skills

Not Applicable

Completed

Conditions: Empathy

Interventions: Behavioral: Empathy Training Modules
Behavioral: Residency Training as usual

First Posted Date: 2011-02-25

Last Posted Date: 2011-02-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 99

Registration Number: NCT01304030

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment

Completed

Conditions: Acromegaly

First Posted Date: 2011-02-24

Last Posted Date: 2015-03-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT01302652

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders

Phase 3

Completed

Conditions: Autism Spectrum Disorders

Interventions: Drug: Placebo
Drug: Mirtazapine

First Posted Date: 2011-02-24

Last Posted Date: 2018-11-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT01302964

Locations: 🇺🇸
Riley Child and Adolescent Psychiatry Clinic Riley Hospital, Indianapolis, Indiana, United States
🇺🇸
Lurie Center -MassGeneral Hospital, Lexington, Massachusetts, United States

Effects of Anorexia Nervosa on Peak Bone Mass

Phase 3

Completed

Conditions: Anorexia Nervosa

Interventions: Drug: Placebo and transdermal 17-beta estradiol
Drug: RhIGF-1 with transdermal 17-beta estradiol

First Posted Date: 2011-02-23

Last Posted Date: 2021-07-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 75

Registration Number: NCT01301183

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy

Completed

Conditions: Mitochondrial Disease

First Posted Date: 2011-02-23

Last Posted Date: 2012-04-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 8

Registration Number: NCT01301235

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy